Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Effects of Menopausal Hormone Therapy
NCT05678192Phase 1Completed
- Start
- Dec 2021
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of estradiol, progesterone and dydrogesterone in menopause (2 arms). Primary endpoints: Evaluation of the severity of menopausal syndrome at 3 months and Quality of Life (WHOQOL-BREF) at 3 months. Started Dec 2021; status: completed.
02
Drugs
estradiolprogesteronedydrogesterone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT05678192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05678192.